Theravance Biopharma Aktie
Finanztrends
Deine Einschätzung
Theravance Biopharma Aktie
Die Theravance Biopharma Aktie rutscht heute ab, verliert -1,23 %.
Was spricht für und gegen Theravance Biopharma in den nächsten Jahren?
Pro
?
M************
?
W******* i* V********
?
M****
Kontra
?
A****************
?
L*********** I********** f** d** n******* J****
?
U****************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Theravance Biopharma im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Theravance Biopharma | -1,23 % | 4,55 % | 8,78 % | 90,53 % | 2,55 % | 63,45 % | 15,83 % |
| Rockwell Medical Inc. | -1,93 % | 13,83 % | 2,61 % | -58,90 % | 22,25 % | -37,82 % | -91,46 % |
| Pacira Pharmaceuticals | -2,94 % | 7,77 % | 5,71 % | 25,42 % | 2,78 % | -34,71 % | -61,72 % |
| Twist Bioscience Corp | 0,23 % | 9,84 % | 11,04 % | -30,57 % | 9,05 % | 22,29 % | -78,31 % |
Kommentare
News
Here's Why Shares in Theravance Biopharma Exploded Today
Shares in Theravance Biopharma (NASDAQ: TBPH) surged by more than 21% as of noontime ET today. The move comes as the market digests the previous day's excellent third-quarter results and corporate
Theravance Sales Jump 83 Percent
Theravance Biopharma (NASDAQ:TBPH), a biopharmaceutical company focused on respiratory medicines and rare disease therapeutics, reported its Q2 2025 results on August 12, 2025. The company’s revenue



